Capital De Empréstimo Alterar Data
AbbVie USD 62.48B 2.05B 2026-06
Abbott USD 29.45B 152M 2026-09
ALKERMES USD 1.47B 5.38M 2026-09
Amgen USD 51.61B 250M 2026-09
AstraZeneca USD 28.8B 2.79B 2026-09
Biogen USD 7.29B 1.7M 2026-09
BioMarin Pharmaceutical USD 3.51B 12.96M 2026-09
Bristol-Myers Squibb USD 41.85B 244M 2026-09
Coherus Biosciences USD 51.08M 496K 2025-12
Eisai JPY 184.62B 19M 2026-09
Eli Lilly USD 46.99B 872M 2026-09
Gilead Sciences USD 23.82B 17M 2026-09
GlaxoSmithKline GBP 21.7B 7.75B 2026-09
J&J USD 35.8B 1.55B 2026-09
Medtronic USD 25.62B 502M 2026-06
Merck USD 49.69B 1.39B 2026-09
Neurocrine Biosciences USD 169.5M 500K 2023-03
Novartis USD 38.38B 893M 2026-09
Perrigo USD 3.28B 600K 2026-09
Pfizer USD 60B 498M 2026-09
Regeneron Pharmaceuticals USD 1.99B 400K 2026-09
Roche Holding CHF 25.22B 2.21B 2026-06
Sanofi EUR 16.28B 1.63B 2026-09
UCB EUR 2.18B 634M 2025-12
Ultragenyx Pharmaceutical USD 1.13B 2M 2026-06
United Therapeutics USD 100M 100M 2024-06
Vertex Pharmaceuticals USD 3.5B 3.39B 2026-09
Zoetis USD 8.3B 749M 2026-09